Xiaocui Guo

Title: Innovations by Xiaocui Guo in Pharmaceutical Composition

Introduction

Xiaocui Guo is a notable inventor based in Jinan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address chronic kidney disease. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving patient care.

Latest Patents

Xiaocui Guo holds a patent for a pharmaceutical composition comprising a mineralocorticoid receptor antagonist. This composition is designed for oral administration to patients suffering from chronic kidney disease. The patent details that when administered, the effective and safe area under the curve (AUC) ranges from 188 ng*h/mL to 3173 ng*h/mL, with a bioavailability of 50% or more in mammals. The composition is intended to be administered at a daily dose of 0.1 to 1.0 mg, ensuring that the AUC remains at a safe and effective level for treating chronic kidney disease.

Career Highlights

Xiaocui Guo is currently associated with Kbp Biosciences Pte. Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on creating effective therapeutic solutions for patients.

Collaborations

Xiaocui Guo collaborates with Zhenhua Huang, contributing to the advancement of their shared goals in pharmaceutical research and development.

Conclusion

Xiaocui Guo's contributions to the field of pharmaceuticals, particularly through his patent on a mineralocorticoid receptor antagonist, highlight his role as an innovator dedicated to improving health outcomes for patients with chronic kidney disease. His work exemplifies the impact of innovation in the medical field.